Molecular docking unveils prospective inhibitors for the SARS-COV-2 main protease
The recent emergence of a novel coronavirus strain (SARS-CoV-2) has stimulated global efforts to identify potential drugs that target proteins expressed by this novel coronavirus. Among these, the main protease of SARS-CoV-2 (3CL-protease (3CLPro), also known as (MPro) is one of the best choices f...
Saved in:
Main Authors: | Ahmad, Fawad, Ikram, Saima, Ahmad, Jamshaid, ur Rehman, Irshad, Khattak, Saeed Ullah, Butt, Sadia, Mushtaq, Maryam |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit Universiti Kebangsaan Malaysia
2021
|
Online Access: | http://journalarticle.ukm.my/17423/1/26.pdf http://journalarticle.ukm.my/17423/ https://www.ukm.my/jsm/malay_journals/jilid50bil5_2021/KandunganJilid50Bil5_2021.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fragment-based in silico design of SARS-CoV-2 main protease inhibitors
by: Ahmad, Sarfraz, et al.
Published: (2021) -
Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
by: Somboon, Tuanjai, et al.
Published: (2021) -
One-pot synthesis, molecular docking, ADMET, and DFT studies of novel pyrazolines as promising SARS-CoV-2 main protease inhibitors
by: Salih, Rezan Huseen Hama, et al.
Published: (2022) -
Cell-based high-throughput screening protocol for discovering antiviral inhibitors against SARS-COV-2 main protease (3CLpro)
by: Rothan, Hussin A., et al.
Published: (2021) -
Identification of pyrazole derivatives of usnic acid as novel inhibitor of SARS-CoV-2 main protease through virtual screening approaches
by: Roney, Miah, et al.
Published: (2023)